| 英文别名 |
CUDC-907;CUDC-907 (CUDC 907, CUDC907);N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide;CUDC907;Fimepinostat;CUDC 907;3S9RX35S5X;Fimepinostat [USAN];pi3k-hdac-inhibitor-i;PI3K/HDAC Inhibitor;PI3K/HDAC Inhibitor centn;MLS006010994;GTPL8952;AOB6775;JOWXJLIFIIOYMS-UHFFFAOYSA-N;HMS3656H04;BCP06870;ABP001045;s2759;BDBM50188961;2341AH;A;D11319;SW219871-1;PI3K/HDAC INHIBITOR CUDC-907;N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide;AC-30227;Fimepinostat (CUDC-907);SCHEMBL1284705;EX-A742;J-690133;DTXSID90712307;5-PYRIMIDINECARBOXAMIDE, N-HYDROXY-2-(((2-(6-METHOXY-3-PYRIDINYL)-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)METHYLAMINO)-;NSC771751;Q27076926;SMR004702794;1339928-25-4;DB11891;MFCD22420823;NSC-771751;CUDC-907 (PI3K/HDAC InhibitorI);NCGC00346692-11;N-Hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide;NCGC00346692-04;NS00072982;5-pyrimidinecarboxamide, N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-;FIMEPINOSTAT [WHO-DD];CCG-269763;SB16569;Fimepinostat (USAN/INN);N-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide;CHEMBL3622533;NCGC00346692-01;HY-13522;FIMEPINOSTAT [INN];CS-1610;CUDC-907 (PI3K/HDAC InhibitorI)?;UNII-3S9RX35S5X;AS-57131;DB-057451;HMS3673E03;AKOS026750340;DA-34958;BRD-K77638923-001-02-0 |